期刊文献+

3,4-二氢喹啉-2(1H)-酮类化合物的研究进展

Progress in the Research of 3,4-Dihydroquinoline-2(1H)-ones
下载PDF
导出
摘要 3,4-二氢喹啉-2(H)-酮具有药物活性,并广泛的应用于医学领域中。本文主要介绍了3,4-二氢喹啉-2(H)-酮的医疗药物应用,分别以N-甲基-N-苯基肉桂酰胺和1,7-烯炔类化合物两种原料进行介绍近几年的研究进展。 3,4-Dihydroquinolin-2(1 H)-one has pharmacological activity and is widely used in the medical field.This paper mainly introduces 3,4-dihydroquinolin-2(H)-.The medical application of ketones has been introduced in recent years with the research of N-methyl-N-phenylcinnamamide and 1,7-enyne compounds.
作者 王秀秀 Wang Xiuxiu(College of Chemical Engineering AnHui University of Science&Technology,Huainan 232001,China)
出处 《山东化工》 CAS 2019年第6期52-53,56,共3页 Shandong Chemical Industry
关键词 3 4-二氢喹啉-2(H)-酮 药物活性 合成方法 3,4-dihydroquinolin-2(H)-one drug activity synthesis method
  • 相关文献

参考文献1

二级参考文献16

  • 1Phillips MR, Yang G, Li S, et al. Suicide and the unique prevalence pattern of schizophrenia in China's Mainland: a retrospective observational study [J]. Lancet, 2004, 364: 1062-1068.
  • 2Meltzer HY, Li Z, Kaneda Y, et al. Serotonin receptors: their key role in drugs to treat schizophrenia [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27:1159-1172.
  • 3De Vry J, Schreiber R, Melon C, et al. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressantlike effects of 8-OH-DPAT and fluoxetine in the rat [J]. Eur Neuropsychopharmacol, 2004, 14: 487-495.
  • 4Leucht S, Pitschel-Walz G, Abraham D, et al. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials [J]. Schizophr Res, 1999, 35:51-68.
  • 5Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials [J]. Schizophr Res, 2003, 61: 123- 136.
  • 6Miyamoto S, Duncan GE, Marx CE, et al. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs [J]. Mol Psychiatry, 2005, 10: 79-104.
  • 7Garzya V, Forbes IT, Gribble AD, et al. Studies towards the identification of a new generation of atypical antipsychotic agents [J]. Bioorg Med Chem Lett, 2007, 17: 400-405.
  • 8Ravina E, Ramos RG, Masaguer CF, et al. Synthesis of N-(2-guanidinoethyl) tetrahydrothieno [3,2-c]azepine, N-(2- guanidinoethyl)tetrahydro-2-benzazepine and N-(2-guanidinoethyl) tetrahydro-1-benzazepine as analogous to antihypertensive agent guanetidine [J]. Synth Commun, 1994, 24: 321-326.
  • 9Braje W, Haupt A, Lubisch W, et al. Tetrahydrobenzazepines as dopamine D3 receptor modulators, their preparation, pharmaceutical compositions and use in the treatment of CNS disorders and renal function disorders: PCT, 2005058328 [P]. 2005-3-31.
  • 10Bondinell WE, Chapin FW, Girard GR, et al. Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chlorosubstituted 1, 2, 3, 4-tetrahydroisoquinolines [J]. J Med Chem, 1980, 23: 506-511.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部